Lenvatinib Administration for Anaplastic Thyroid Carcinoma with Brain Metastasis

We describe the use of the tyrosine kinase inhibitor lenvatinib in a patient with brain tumor metastases from anaplastic thyroid carcinoma (ATC). A 52-year-old Japanese male presented with consciousness loss. Imaging revealed a thyroid tumor and multiple brain lesions. After the brain tumor's r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta medica Okayama 2023-04, Vol.77 (2), p.227
Hauptverfasser:	Obayashi, Atsuto, Aoki, Kazuma, Wada, Tadayoshi, Furuie, Hiromi, Kuraoka, Kazuya, Hamamoto, Takao, Tatsukawa, Takaharu
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Brain Neoplasms Humans Male Middle Aged Thyroid Carcinoma, Anaplastic - drug therapy Thyroid Carcinoma, Anaplastic - pathology Thyroid Neoplasms
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!